WEST LAFAYETTE, Ind. – Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected ...

Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 ...

Qian Zhou , MD, MHSc, Christine Moore , ART, Sarah Eden , RN, Agnes Tong , MSc, Allison McGeer , MD, FRCPC and Mount Sinai Hospital Infection Control Team Objective. Most nosocomial acquistion of ...

Objective. To detect the burden of vancomycin‐resistant Enterococcus (VRE) colonization among pediatric oncology patients and to determine risk factors for VRE acquisition. Design. Retrospective ...

Background: Our institution experienced an increase in the frequency of vancomycin-resistant enterococci (VRE) clinical isolates. Surveillance cultures upon hospital admission for patients at high ...

WEST LAFAYETTE, Ind. — With antimicrobial resistance on the rise, many infections once easily treated are becoming fatal. Vancomycin-resistant enterococci (VRE) is to blame for more than 5% of all ...

Antibiotic exposure and dirty hands were factors linked to nursing home contamination with the multidrug-resistant bacteria vancomycin-resistant Enterococci, or VRE, a new study finds. The report was ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Stopping contact precautions for MRSA and ...

Please provide your email address to receive an email when new articles are posted on . Exposure to the antibiotics did not increase the risk for vancomycin-resistant Enterococcus colonization. Few ...

HOUSTON -- (Aug. 12, 2019) -- To combat the rise of drug-resistant bacteria, researchers are examining how one superbug adapts to fight an antibiotic of last resort, hoping to find clues that can ...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant bacterial pathogens, including MRSA and VRE ...

C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...